NT
Nok Therapeutics, Inc.
SEC filingBiotechnology · Cranberry Twp., PA
Amount raised$3Ksold at filing
Total offering$3K
Investors in the raise14count reported to the SEC
FiledMay 1, 2026first sale Jun 11, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Brian CogleyExecutive Officer, Director
David MehalickPromoter
Michael LewisPromoter
Bruce CassidyDirector
Robert LewisExecutive Officer, Director, Promoter
Martin LewisDirector
Executive officers, directors and promoters as listed on the Form D.